A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Jun. 8];2(S1):S29. Available from: https://skin.dermsquared.com/skin/article/view/281